This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Aude Figuccia, Ph.D.
Regulatory Affairs CMC Senior Manager at Novartis


Aude is a project leader in Regulatory Affairs CMC at Novartis. In her role, she has led global CMC regulatory strategies and health authority interactions for the development and registration of oligonucleotide therapeutics. Aude has over a decade of experience in the pharmaceutical industry. In 2015, she joined Novartis as a laboratory head in process chemistry within the technical R&D department, where she worked on multiple late phase and life-cycle management projects. Aude obtained a Ph.D. in organic chemistry from the University of Oxford, U.K., in which she researched total asymmetric syntheses of iminosugars.

Agenda Sessions

  • Lessons Learned on the Evaluation of Terminal Sterilization for Oligonucleotide Drug Products